Phospho-Tau (Ser396) Antibody

About the Target

Phospho-Tau (Ser396) refers to the phosphorylation of the microtubule-associated protein Tau at serine 396, a key modification in normal neuronal function and the pathology of neurodegenerative diseases. Tau is an intrinsically disordered protein composed of an N-terminal projection domain, a proline-rich region, microtubule-binding repeats, and a C-terminal tail that contains the Ser396 residue. Depending on the literature source, TAU may also be discussed as Phospho-Tau (Ser396) and MAPTL.

Reported cellular context includes cellmembrane, cytoplasm, cytoskeleton, and membrane, which can matter when signal is compared across treatments or changing cell states. Following TAU across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

TAU is commonly interpreted in the context of neuroscience and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cellmembrane, cytoplasm, and cytoskeleton, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cellmembrane, cytoplasm, and cytoskeleton across matched conditions
• compartment-specific patterns relevant to neuronal polarity, transport, or synaptic context
• signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation
• differences between total target abundance and site-specific regulation when modified forms are compared

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for TAU. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in TAU reflect biology rather than handling. When interpreting TAU, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep TAU trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.